Overview of a rational approach to design type I 17β-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation
- 4 January 1999
- journal article
- Published by Elsevier
- Vol. 66 (4) , 179-191
- https://doi.org/10.1016/s0960-0760(98)00043-0
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Intracellular regulation of 17β-hydroxysteroid dehydrogenase type 2 catalytic activity in A431 cellsJournal of Endocrinology, 1997
- Synthesis of 16-[carbamoyl(bromomethyl)alkyl]estradiol: a potential dual-action inhibitor designed to blockade estrogen action and biosynthesisJournal of the Chemical Society, Perkin Transactions 1, 1996
- Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesisThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- A Convenient Synthetic Method for Alpha-Alkylation of Steroidal 17-Ketone: Preparation of 16β(THPO-Heptyl)-EstradiolSynthetic Communications, 1995
- Aromatase inhibitors in the treatment of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal womenJournal of Clinical Endocrinology & Metabolism, 1993
- Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Hydrogen bonding in steroidogenesis: Studies on new heterocyclic analogs of estrone that inhibit human estradiol 17β-dehydrogenaseBiochemical and Biophysical Research Communications, 1991
- The role of endocrine therapy in primary breast cancerJournal of Steroid Biochemistry, 1990
- The affinity alkylators, 11α-bromoacetoxyprogesterone and estrone 3-bromoacetate, modify a common histidyl residue in the active site of human placental 17β,20α-hydroxysteroid dehydrogenaseThe Journal of Steroid Biochemistry and Molecular Biology, 1986